tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

USANA Health Sciences Inc

USNA
Add to Watchlist
14.490USD
+0.350+2.48%
Close 09-21 16:00（ET）
267.53MMarket Cap
29.25P/E TTM
After-hours 18:30 (ET)14.490USD+0.010+0.07%

USANA Health Sciences Inc

14.490
+0.350+2.48%
Overview
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

USNA Financials

See USANA Health Sciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
267.53M
Dividend TTM
0.00
P/E TTM
29.25
EPS TTM
0.50
Revenue
925.26M
Net Profit
42.03M
ROE
1.65%
ROA
1.23%

USANA Health Sciences Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
-1.16/0.43
Revenue / Forecast
223.27M/235.00M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-321.78%-1.16
-17.24%0.41
-141.60%-0.10
-164.13%-0.36
-4.65%0.52
-42.77%0.49
-73.35%0.23
-5.70%0.56
-38.89%0.55
-9.53%0.86
31.56%0.88
--0.59
--0.89
--0.95
--0.67
--2.94
----
----
----
----
Revenue
-5.33%223.27M
0.27%250.22M
5.89%226.20M
6.72%213.67M
10.79%235.85M
9.54%249.54M
-3.38%213.61M
-6.16%200.22M
-10.64%212.87M
-8.28%227.80M
-3.02%221.08M
-8.54%213.37M
-9.93%238.20M
-8.98%248.36M
-14.72%227.96M
-14.96%233.30M
-21.48%264.47M
-11.40%272.87M
-13.92%267.30M
-8.09%274.35M
Net Profit
-321.46%-21.38M
-20.07%7.51M
-139.85%-1.77M
-161.49%-6.52M
-7.45%9.65M
-43.15%9.40M
-73.43%4.45M
-6.52%10.61M
-39.67%10.43M
-10.04%16.54M
31.04%16.77M
-23.99%11.35M
-9.74%17.29M
-18.19%18.38M
-37.03%12.79M
-45.38%14.93M
-49.90%19.16M
-26.62%22.47M
-48.72%20.32M
-10.41%27.33M
Net Margin
-382.70%-12.52%
-25.29%2.78%
-133.59%-0.71%
-158.85%-3.12%
-9.64%4.43%
-48.72%3.72%
-72.32%2.10%
-0.38%5.30%
-32.49%4.90%
-1.92%7.26%
35.11%7.58%
--5.32%
--7.26%
--7.40%
--5.61%
--7.34%
----
----
----
----
Gross Margin
-0.47%78.35%
-3.47%76.25%
-4.63%78.16%
-4.03%77.15%
-2.88%78.72%
-2.60%78.98%
1.35%81.95%
0.41%80.39%
-0.93%81.05%
0.78%81.09%
1.54%80.86%
--80.07%
--81.81%
--80.46%
--79.63%
--80.87%
----
----
----
----
Debt to assets ratio
--0.00%
-38.50%1.89%
-38.70%1.88%
--0.00%
--0.00%
1368.58%3.08%
2374.70%3.07%
--0.00%
--0.00%
--0.21%
--0.12%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
Income Statement
Revenue
-5.33%223.27M
0.27%250.22M
5.89%226.20M
6.72%213.67M
10.79%235.85M
9.54%249.54M
-3.38%213.61M
-6.16%200.22M
-10.64%212.87M
-8.28%227.80M
-3.02%221.08M
-8.54%213.37M
-9.93%238.20M
-8.98%248.36M
-14.72%227.96M
-14.96%233.30M
-21.48%264.47M
-11.40%272.87M
-13.92%267.30M
-8.09%274.35M
Operating profit
-45.32%9.14M
-11.47%13.87M
110.10%17.25M
-92.15%1.22M
-6.29%16.72M
-36.49%15.67M
-66.10%8.21M
-11.39%15.60M
-26.89%17.84M
-8.09%24.67M
7.40%24.22M
-22.20%17.61M
-16.91%24.40M
-18.82%26.84M
-28.42%22.55M
-44.49%22.63M
-45.34%29.37M
-25.18%33.07M
-40.03%31.50M
-10.11%40.77M
Net Profit
-321.46%-21.38M
-20.07%7.51M
-139.85%-1.77M
-161.49%-6.52M
-7.45%9.65M
-43.15%9.40M
-73.43%4.45M
-6.52%10.61M
-39.67%10.43M
-10.04%16.54M
31.04%16.77M
-23.99%11.35M
-9.74%17.29M
-18.19%18.38M
-37.03%12.79M
-45.38%14.93M
-49.90%19.16M
-26.62%22.47M
-48.72%20.32M
-10.41%27.33M
Balance Sheet
Current assets
7.33%281.07M
4.56%294.23M
3.30%288.40M
-41.47%264.06M
-37.51%261.87M
-33.17%281.39M
-33.17%279.19M
15.55%451.19M
8.11%419.08M
6.36%421.07M
8.68%417.75M
14.45%390.46M
13.35%387.65M
8.82%395.88M
5.28%384.38M
-7.40%341.15M
-10.35%342.00M
-2.52%363.79M
-14.15%365.12M
-4.56%368.43M
Total current liabilities
-13.11%105.67M
-14.66%117.24M
-7.92%128.56M
3.38%118.66M
17.06%121.63M
21.98%137.38M
17.48%139.63M
1.97%114.78M
-8.73%103.90M
-13.51%112.63M
-17.37%118.84M
-10.56%112.56M
-14.79%113.84M
-17.56%130.22M
-10.55%143.83M
-20.33%125.85M
-12.68%133.59M
4.30%157.97M
-4.33%160.79M
-1.80%157.96M
Total assets
-4.26%703.21M
-1.02%738.97M
-0.71%742.91M
8.24%726.59M
16.33%734.53M
18.64%746.60M
18.24%748.19M
11.67%671.31M
4.77%631.42M
3.92%629.27M
6.07%632.76M
8.11%601.15M
8.02%602.68M
5.69%605.53M
3.26%596.55M
-3.95%556.06M
-5.66%557.96M
-1.98%572.92M
-9.85%577.74M
0.24%578.95M
Total liabilities
-11.23%132.24M
-11.40%144.18M
-3.22%156.64M
4.93%145.04M
24.96%148.97M
25.86%162.72M
19.41%161.86M
5.71%138.22M
-10.94%119.21M
-13.91%129.29M
-16.36%135.56M
-9.80%130.75M
-13.24%133.86M
-17.92%150.18M
-11.25%162.08M
-19.40%144.96M
-10.73%154.28M
0.68%182.97M
-8.34%182.62M
-4.54%179.87M
Total equity
-2.49%570.97M
1.87%594.79M
-0.01%586.27M
9.09%581.55M
14.32%585.56M
16.78%583.87M
17.93%586.33M
13.33%533.09M
9.25%512.21M
9.80%499.99M
14.44%497.20M
14.42%470.39M
16.14%468.82M
16.77%455.35M
9.96%434.47M
3.01%411.10M
-3.57%403.68M
-3.19%389.95M
-10.53%395.12M
2.56%399.08M
Cash Flow Statement
Net operating income
90.86%23.32M
-36.97%9.76M
-158.60%-3.39M
-106.64%-1.96M
52.92%12.22M
-12.45%15.48M
-77.77%5.79M
32.83%29.53M
-16.34%7.99M
37.79%17.68M
-35.69%26.02M
-23.66%22.23M
-34.64%9.55M
-34.86%12.83M
62.36%40.46M
-22.31%29.13M
-62.68%14.61M
0.21%19.70M
-47.99%24.92M
-23.59%37.49M
Net investment
2.52%-4.06M
32.98%-2.60M
100.54%1.11M
-36.78%-3.20M
-169.21%-4.16M
4.74%-3.88M
-2701.67%-205.14M
-60.80%-2.34M
-963.69%-1.55M
-20.43%-4.07M
-123.10%-7.32M
59.37%-1.45M
104.81%179.00K
-89.14%-3.38M
-4.09%-3.28M
44.53%-3.58M
-149.20%-3.72M
42.16%-1.79M
85.29%-3.15M
-136.16%-6.45M
Net financing
63.67%-14.03M
74.83%-3.64M
-41.33%13.45M
-1155.13%-979.00K
-2753.66%-38.61M
-21.10%-14.47M
3384.80%22.93M
99.33%-78.00K
-2360.00%-1.35M
-273.43%-11.95M
538.67%658.00K
-26356.82%-11.64M
99.47%-55.00K
83.67%-3.20M
99.54%-150.00K
99.91%-44.00K
67.46%-10.30M
72.20%-19.59M
-6773.94%-32.45M
-108809.30%-46.83M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its total revenue reached 925.26M, with a year-on-year change of 854.50M.

What are the current assets of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its current assets were 288.40M, with a year-on-year change of 3.30.

What are the total assets of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its total assets of USANA Health Sciences Inc were 742.91M, with a year-on-year change of -0.71.

What are the total liabilities of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its total liabilities of USANA Health Sciences Inc were 156.64M, with a year-on-year change of -3.22.

What is the total equity of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its total equity of USANA Health Sciences Inc was 586.27M, with a year-on-year change of -0.01.

What is the net operating income of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its net operating income of USANA Health Sciences Inc was 50.86M, with a year-on-year change of -23.31.

What is the net investment of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its net investment of USANA Health Sciences Inc was -10.12M, with a year-on-year change of 95.25.

What is the net financing of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its net financing of USANA Health Sciences Inc was -40.60M, with a year-on-year change of -525.03.

What is the Earnings Per Share (EPS) of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.58, with a year-on-year change of -73.61.

What is the net income of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its net income was 10.76M, with a year-on-year change of -74.40.

What is the net margin of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its net profit margin was 1.24, with a year-on-year change of -74.80.

What is the gross margin of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its gross margin was 78.29, with a year-on-year change of -3.50.

What is the debt-to-asset ratio of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its debt-to-asset ratio was 1.88, with a year-on-year change of -38.70.

What is the Return on Equity (ROE) of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its Return on Equity (ROE) was 2.02, with a year-on-year change of -75.26.

What is the Return on Assets (ROA) of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its Return on Assets (ROA) was 1.54, with a year-on-year change of -74.73.

What is the operating profit of USANA Health Sciences Inc?

According to USANA Health Sciences Inc's FY2025 earnings report, its operating profit was 50.86M, with a year-on-year change of -23.31.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy